Recombinant botulinum neurotoxin serotype A1 in vivo characterization
Abstract Clinically used botulinum neurotoxins (BoNTs) are natural products of Clostridium botulinum. A novel, recombinant BoNT type A1 (rBoNT/A1; IPN10260) has been synthesized using the native amino acid sequence expressed in Escherichia coli and has previously been characterized in vitro and ex v...
Saved in:
Main Authors: | Cindy Périer, Vincent Martin, Sylvie Cornet, Christine Favre‐Guilmard, Marie‐Noelle Rocher, Julien Bindler, Stéphanie Wagner, Emile Andriambeloson, Brian B. Rudkin, Rudy Marty, Alban Vignaud, Matthew Beard, Stephane Lezmi, Mikhail Kalinichev |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/08d7dae9cde34694bf838b65c8d1a5b6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum Neurotoxin-Producing Bacteria. Isn’t It Time that We Called a Species a Species?
by: Theresa Smith, et al.
Published: (2018) -
Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified <named-content content-type="genus-species">Clostridium botulinum</named-content> Strain
by: Sabine Pellett, et al.
Published: (2016) -
Type E Botulinum Neurotoxin-Producing <named-content content-type="genus-species">Clostridium butyricum</named-content> Strains Are Aerotolerant during Vegetative Growth
by: Serena Camerini, et al.
Published: (2019) -
Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6
by: Molly S. Moritz, et al.
Published: (2018) -
Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
by: Jeongkyeong Jang, et al.
Published: (2021)